Oracle Corporation $ORCL Position Cut by CORDA Investment Management LLC.

CORDA Investment Management LLC. lowered its position in Oracle Corporation (NYSE:ORCLFree Report) by 7.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,636 shares of the enterprise software provider’s stock after selling 595 shares during the quarter. CORDA Investment Management LLC.’s holdings in Oracle were worth $1,669,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Brighton Jones LLC raised its stake in shares of Oracle by 189.3% during the fourth quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock valued at $25,593,000 after purchasing an additional 100,494 shares in the last quarter. Revolve Wealth Partners LLC increased its stake in Oracle by 8.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock valued at $903,000 after buying an additional 404 shares during the period. GAMMA Investing LLC increased its stake in Oracle by 8.1% during the 1st quarter. GAMMA Investing LLC now owns 34,011 shares of the enterprise software provider’s stock valued at $4,755,000 after buying an additional 2,546 shares during the period. Advisor Resource Council bought a new stake in shares of Oracle during the 1st quarter worth about $328,000. Finally, Inlight Wealth Management LLC acquired a new stake in shares of Oracle in the 1st quarter worth approximately $28,000. 42.44% of the stock is currently owned by institutional investors and hedge funds.

Oracle Price Performance

ORCL opened at $291.95 on Monday. The firm has a market capitalization of $832.28 billion, a P/E ratio of 67.58, a PEG ratio of 3.14 and a beta of 1.53. The stock has a fifty day moving average of $271.71 and a 200-day moving average of $216.40. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72.

Oracle (NYSE:ORCLGet Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The business had revenue of $14.93 billion for the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities analysts forecast that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be issued a $0.50 dividend. The ex-dividend date is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. Oracle’s dividend payout ratio is currently 46.30%.

Insiders Place Their Bets

In related news, insider Michael D. Sicilia sold 33,845 shares of the firm’s stock in a transaction that occurred on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the sale, the insider directly owned 132,656 shares in the company, valued at approximately $42,603,800.96. This trade represents a 20.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Naomi O. Seligman sold 2,222 shares of the business’s stock in a transaction that occurred on Friday, September 26th. The shares were sold at an average price of $288.91, for a total transaction of $641,958.02. Following the transaction, the director directly owned 29,225 shares in the company, valued at $8,443,394.75. The trade was a 7.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,769 shares of company stock valued at $36,428,967 over the last ninety days. Insiders own 40.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on ORCL. Berenberg Bank boosted their price objective on Oracle from $202.00 to $306.00 and gave the stock a “hold” rating in a research note on Monday, September 15th. Melius Research boosted their price target on shares of Oracle from $270.00 to $370.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Scotiabank upped their price target on shares of Oracle from $350.00 to $360.00 and gave the company an “outperform” rating in a report on Friday. Citigroup reaffirmed a “buy” rating on shares of Oracle in a research note on Friday, October 10th. Finally, Baird R W upgraded shares of Oracle to a “strong-buy” rating in a report on Wednesday, October 8th. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Oracle presently has an average rating of “Moderate Buy” and an average price target of $323.40.

Read Our Latest Stock Analysis on ORCL

Oracle Company Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

See Also

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.